Home › Funds › Metavasi Capital LP › HNGE
Metavasi Capital LP position in HNGE
HINGE HEALTH INC · Technology
Metavasi Capital LP reported holding 231,000 shares of HNGE (HINGE HEALTH INC) in its Q3 2026 13F filing — a position valued at US$22.5M, representing 7.95% of its reported portfolio and ranking #3 among its reported holdings. Metavasi Capital LP has disclosed HNGE holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Metavasi Capital LP's HNGE position evolved
Metavasi Capital LP first disclosed a stake in HNGE in Q2 2026 at 125,000 shares (US$10.4M). The position peaked in Q3 2026 at 231,000 shares, worth US$22.5M. Across 2 filings, Metavasi Capital LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 231,000 shares valued at US$22.5M — an increase of 106,000 shares quarter over quarter.. Notable position changes include a 85% increase in Q3 2026 (shares rose 25% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 125.00K | $10.38M | New |
| Q3 2026 | 231.00K | $22.46M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About HNGE and 13F data
HNGE (HINGE HEALTH INC) is a Technology company. 85 other funds we track also report a position in HNGE — the largest reported positions include 11.2 Capital Management, LLC (US$228.9M), Divisadero Street Capital Management, LP (US$125.8M), Deer Management Co. LLC (US$122.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding HNGE
- 11.2 Capital Management, LLC 2.35M sh · $228.91M · Q3 2026
- Divisadero Street Capital Management, LP 1.29M sh · $125.76M · Q3 2026
- Deer Management Co. LLC 1.26M sh · $122.40M · Q3 2026
- BIT Capital GmbH 1.22M sh · $118.97M · Q3 2026
- OBERWEIS ASSET MANAGEMENT INC/ 994.90K sh · $96.74M · Q3 2026
- BRAIDWELL LP 655.31K sh · $63.72M · Q3 2026
- RTW INVESTMENTS, LP 500.00K sh · $48.62M · Q3 2026
- Shannon River Fund Management LLC 494.63K sh · $48.10M · Q3 2026
- Vitruvian Partners LLP 450.00K sh · $43.76M · Q3 2026
- Tyro Capital Management LLC 435.61K sh · $42.36M · Q3 2026
- EMERALD ADVISERS, LLC 360.05K sh · $35.01M · Q3 2026
- APIS CAPITAL ADVISORS, LLC 336.00K sh · $32.67M · Q3 2026
More on Metavasi Capital LP
FAQ
How long has Metavasi Capital LP held HNGE?
Metavasi Capital LP has disclosed HNGE holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Metavasi Capital LP's current position in HNGE?
As of Q3 2026, Metavasi Capital LP holds 231.00K shares of HNGE (HINGE HEALTH INC), valued at $22.46M, representing 7.95% of its reported portfolio and ranking #3.
Has Metavasi Capital LP been buying or selling HNGE?
In the latest 13F filing (Q3 2026), Metavasi Capital LP increased its position in HNGE. The position peaked in Q3 2026 at 231.00K shares.
Which other funds hold HNGE?
Other major institutional holders of HNGE include 11.2 Capital Management, LLC, Divisadero Street Capital Management, LP, Deer Management Co. LLC, among 85 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.